funny games with xt's, page-11

re: re fda orpahn drug staus for cf lombard , sorry for the late reply.

i stillrek on $3.50 once we get revenues

also note in PXS presenation they have moved rev from aridol to end of 2005 , as oppossed to first rev in early 2006.

these guys are very aware of marketing risk and how companies can faulter when rev expectations arent met.
So id say number are conservative and topping up at this level is a good idea .

Looks like there has been a insto seller around ,but he should be close to out.

also this prob move more tomorrow as when it hits the press.
and yes im looking for a few longnecks of waikato and some puha and pipi's